𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia

✍ Scribed by Sampa Ghoshal (Gupta); Heinz Baumann; Meir Wetzler


Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
350 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

✦ Synopsis


We have demonstrated that constitutive signal transducer and activator of transcription (STAT) 3 activity, observed in approximately 50% of acute myeloid leukemia (AML) cases, is associated with adverse treatment outcome. Constitutive STAT3 activation may result from the expression of oncogenic protein tyrosine kinases or from autocrine stimulation by hematopoietic growth factors. These causes are generally neither necessary nor sufficient for leukemogenesis; additional transforming events or growth stimulatory processes are needed. Here we review the literature addressing epigenetic regulation as a mechanism controlling STAT3 signaling in AML. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells.


πŸ“œ SIMILAR VOLUMES


Signal transducer and activator of trans
✍ Dae Joon Kim; Keith S. Chan; Shigetoshi Sano; John DiGiovanni πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

## Abstract Signal transducer and activator of transcription 3 (Stat3) is one of a family of cytoplasmic proteins that participate in normal cellular responses to cytokines and growth factors as transcription factors. Stat3 modulates various physiological functions including cell survival, cell‐cyc

Epigenetic and genetic analysis of the s
✍ Mandy Wagner; Karin Schmelz; Bernd DΓΆrken; Ingo Tamm πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 478 KB

Survivin, an inhibitor of apoptosis (IAP) protein plays a dual role in regulation of mitosis and inhibition of apoptosis. Survivin is expressed in embryonic and fetal organs as well as in most human cancers, but not in normal differentiated adult tissues. In this study we investigated the molecular

Hypoxia induces chemoresistance in ovari
✍ Karuppaiyah Selvendiran; Anna Bratasz; M. Lakshmi Kuppusamy; Mia F. Tazi; Brian πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 384 KB

## Abstract Signal transducer and activator of transcription 3 (STAT3) is activated in a variety of human cancers, including ovarian cancer. The molecular mechanism by which the STAT3 is activated in cancer cells is poorly understood. We observed that human ovarian xenograft tumors (A2780) in mice